TLR2 and influenza: We have shown that the TLR-2 agonist PEG-Pam2Cys provides mice with immediate protection against influenza virus and does not impact the induction of influenza-specific immunity following subsequent exposure to virus, which provides both homotypic and heterosubtypic protection.